Protective specific immunity induced by cyclophosphamide plus tumor necrosis factor α combination treatment of EL4-lymphoma-bearing C57BL/6 mice Christian M. KrawczykSrdan VerstovšekM. Jane Ehrke Original Article Pages: 347 - 357
Suppression of cytotoxic T lymphocyte activity by γ/δ T cells in tumor-bearing mice Naohiro SeoKohji Egawa Original Article Pages: 358 - 366
Granulocyte/macrophage-colony-stimulating factor augments the induction of antibodies, especially anti-idiotypic antibodies, to therapeutic monoclonal antibodies Peter RagnhammarJan FagerbergHakan Mellstedt Original Article Pages: 367 - 375
Activation of human lymphocytes by a monoclonal antibody to B lymphoblastoid cells; molecular mass and distribution of binding protein Britta HardyMichal GalliAbraham Novogrodsky Original Article Pages: 376 - 382
A rat monoclonal anti-(human CD2) andL-leucine methyl ester impacts on human/SCID mouse graft and B lymphoproliferative syndrome Fataki BombilJean Pierre KintsDominique Latinne Original Article Pages: 383 - 389
CD8 T cell activation after intravenous administration of CD3×CD19 bispecific antibody in patients with non-Hodgkin lymphoma Gijsbert C. de GastInez-Anne HaagenBert J. E. G. Bast Original Article Pages: 390 - 396
Generation of cytotoxic effector cells against human melanoma Stanley P. L. LeongYuan-Ming ZhouAugustine Y. Lin Original Article Pages: 397 - 409
Induction of tumor-specific T lymphocyte responses in vivo by prothymosin α Constantin N. BaxevanisAngelos D. GritzapisMichael Papamichail Original Article Pages: 410 - 418
